CORT fundamentals
Key facts
Market capitalization5.73 BUSD
Basic EPS (TTM)1.35USD
Founded1998
CEOJoseph K. Belanoff
Websitecorcept.com
About
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
15%
18%
21%
24%
27%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
50.00 M
100.00 M
150.00 M
200.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
CORT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company